Susquehanna International Group, LLP Entera Bio Ltd. Transaction History
Susquehanna International Group, LLP
- $560 Billion
- Q3 2024
A detailed history of Susquehanna International Group, LLP transactions in Entera Bio Ltd. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 20,658 shares of ENTX stock, worth $35,738. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,658
Previous 28,856
28.41%
Holding current value
$35,738
Previous $53,000
26.42%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ENTX
# of Institutions
21Shares Held
5.34MCall Options Held
2.6KPut Options Held
100-
Knoll Capital Management, LLC Miami, FL3.88MShares$6.72 Million3.64% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY649KShares$1.12 Million0.01% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT411KShares$711,1610.11% of portfolio
-
Ubs Group Ag143KShares$246,9520.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny61.2KShares$105,8760.0% of portfolio
About Entera Bio Ltd.
- Ticker ENTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,809,900
- Market Cap $49.8M
- Description
- Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed ...